Cover Image
市場調查報告書

切除設備:技術和全球市場

Ablation Devices: Technologies and Global Markets

出版商 BCC Research 商品編碼 294446
出版日期 內容資訊 英文 221 Pages
訂單完成後即時交付
價格
Back to Top
切除設備:技術和全球市場 Ablation Devices: Technologies and Global Markets
出版日期: 2016年12月08日 內容資訊: 英文 221 Pages
簡介

世界切除設備市場規模2015年達28億美元。2016年至2021年預計將至11.6%CAGR (年複合成長率) 從2016年31億美元到2021年的54億美元。

本報告針對世界切除設備市場、提供市場概要與主要技術概要、技術分類、產品分類、手術分類、治療方法分類、地區分類ズ市場ソ現狀シ見通ウメ分析エペシシパズ、特許分析與競合情勢メ概括ウ、主要參入企業ソк①иャユюスジメネシバサゆネエ。

第1章 介紹

  • 調查和目的
  • 調查實施理由
  • 調查範圍
  • 主要讀者
  • 資訊來源、調查方法
  • 分析師的簡歷
  • 相關報告
  • BCC線上服務
  • 免責

第2章 摘要整理

第3章 切除市場概要

  • 切除設備:技術趨勢與創新
  • 傳統外科程序種類與缺點
  • 政府法規、醫療協會、食品醫藥品局 (FDA) 、及國際法規機關
  • 產業結構與供應鏈流程
  • 市場影響成長人口動態、發病率及得病率,以及其他參數
    • 癌症相關發生、得病率
    • 心臟疾病相關發生、得病率
    • 眼科相關發生、得病率
    • 主要產品相關FDA指南
  • 醫療費用補償狀況
  • 市場動態
  • 全球切除設備市場的發展阻礙因素
  • 切除設備市場上的機會及課題

第4章 切除市場分析、技術分類

  • 熱技術市場
  • 電力切除療法
  • 放射線技術
  • 高頻 (RFID) 技術
  • 超音波
    • 微波
    • 熱水
    • 非熱切除技術
    • 冷凍切除
    • 油壓、機械式

第5章 切除市場分析:產品分類

  • 電力
  • 電燒灼
  • 電子近距離放射療法
  • 放射線
  • 近距離放射療法
    • 高線量率(HDR)近距離放射治療
    • 脈衝線量率近距離放射治療
    • 永久性核種近距離放射治療,以及低劑量率(LDR)近距離放射治療
  • 立體定位放射治療、定位的放射線治療
  • 影像導航放射治療(IGRT)
  • 強度調控放射治療(IMRT)
  • 定位的放射線治療(SBRT)
  • 質子電子束治療
  • 高頻
  • 溫度控制射頻消融術設備
  • 液體冷卻RF切除
  • 機器人導管操縱系統
  • 光/雷射
  • 冷雷射
  • 準分子雷射
  • 超音波
  • 高能聚焦超音波療法(HIFU)
  • 磁共鳴誘導超音波(MRGUS)
  • 超音波外科系統
  • 體外震波碎石術
  • 微波切除
  • 熱水切除/子宮內膜熱水球囊切除設備
  • 冷凍切除
  • 組織接觸探針
  • 組織噴霧探針
  • 表皮、皮下冷凍切除設備
  • 機器人切除技術發展
  • 具機器人性的性質的各種程序
    • 可動導管
    • HEARTLANDER
    • 機器人放射線治療
    • 心律不整使用的機器人切除
    • 導管切除使用的主要機器人系統

第6章 切除市場分析:手術分類

  • 美容:皮膚活性化、緊膚
  • 臉皮膚活性化用高週波(RF)
  • 美容:塑身、消脂、橘皮組織的消除
  • 良性攝護腺肥大症切除
  • 經尿道針刺消融
  • 前列腺癌的雷射摘出
  • 心房顫動切除
  • 癌症/腫瘤切除
  • 月經過多/子宮內膜切除
  • 脊髓除壓、脫神經
  • 應力性尿失禁
  • 靜脈瘤切除
  • 子宮肌瘤
  • 其他手術

第7章 切除市場分析:治療法分類

  • 癌症/腫瘤
  • 心血管
  • 眼科
  • 美容術
  • 婦科
  • 泌尿器官
  • 前列腺癌症用冷凍切除
  • 整形外科
  • 形成手術用高頻切除
  • 疼痛管理
  • 其他

第8章 競爭情況

  • 淨空、承認
  • 收購
  • 合併
  • 產品發售

第9章 地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區 (ROW)

第10章 專利分析

  • 專利分析:市場企業分類
  • 專利分析:年度分類

第11章 企業檔案

  • ABBOTT LABORATORIES
  • ACCURAY INC.
  • ALCON LABORATORIES INC.
  • ANGIODYNAMICS INC.
  • ATRICURE INC.
  • BIOSENSE WEBSTER
  • BOSTON SCIENTIFIC CORP.
  • BTG PLC
  • CONMED CORP.
  • C.R. BARD INC.
  • EDAP TMS S.A.
  • ELEKTA AB
  • HAYLARD HEALTH INC.
  • HOLOGIC INC.
  • INTEGRA LIFESCIENCES HOLDINGS CORP.
  • JAPAN LIFELINE CO. LTD.
  • MEDTRONIC PLC
  • MERIT MEDICAL SYSTEMS INC.
  • MISONIX INC.
  • OLYMPUS CORP.
  • SMITH & NEPHEW PLC
  • ST. JUDE MEDICAL INC.
  • STRYKER CORP.
  • TERUMO MEDICAL CORP.
  • VARIAN MEDICAL SYSTEMS INC.

第12章 附錄

圖表列表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC163B

REPORT HIGHLIGHTS

The global market for ablation devices reached $2.8 billion in 2015. The market should reach $3.1 billion in 2016 and $5.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 11.6% from 2016 to 2021.

This report provides:

  • An overview of the global market for ablation devices.
  • Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • A breakdown of the market into segments such as types of technology, products, major market players, application, geography, and factors influencing demand.
  • A look at factors inhibiting market growth such as pricing, reimbursement policies, and stringent regulatory impositions.
  • Discussion covering the role of supply chain members from manufacturers to surgeons.
  • Profiles of major players in the industry.

SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global ablation market by technologies, product categories, therapeutic segments, key procedures and geographic markets. The report includes key technologies involved in thermal ablation techniques and nonthermal ablation techniques. The report discusses the role of supply chain members from manufacturers to surgeons. The report has an in-depth analysis of key companies operating in the global ablation market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and Japan.

The ablation devices market is mainly segmented into two classes: thermal and nonthermal technologies. Thermal technologies are further segmented into electrical, radiation, radio frequency, light, ultrasound, microwave and hydrothermal. The nonthermal technology market is segmented into cryotherapy and hydromechanical. The ablation devices technology market is further segmented on the basis of products offered for in-depth analysis of technology markets during the analysis period. The market study is detailed for technology based on procedures as well as its further implication on the therapeutic area. These two segmentations are also discussed in detail for the given period. The market is segmented by geography into the North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Conmed, Varian Medical Systems Inc., Medtronic Inc., Boston Scientific Corp., Olympus Corp., Smith & Nephew, C.R. Bard Inc., and others.

ANALYST'S CREDENTIALS

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market and the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to assist the market players to make beneficial strategies. Ms. Jeevane holds an MBA in marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVE
  • STUDY BACKGROUND
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • SOURCE OF INFORMATION AND METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR ABLATION DEVICES BY REGION, 2015-2021 ($ MILLIONS)

CHAPTER 3 - ABLATION MARKET OVERVIEW

  • ABLATION DEVICES: TECHNOLOGY TRENDS AND INNOVATIONS
  • TYPES OF CONVENTIONAL SURGICAL PROCEDURES AND DRAWBACKS
    • HEART SURGERY
    • PLASTIC SURGERY
    • BRAIN SURGERY
    • CANCER SURGERY
    • ORTHOPEDIC SURGERY
  • GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, FDA AND INTERNATIONAL REGULATORY AGENCIES
    • TABLE 1: DEVICES YET TO BE APPROVED FOR ATRIAL FIBRILLATION TREATMENT
  • INDUSTRY STRUCTURE AND SUPPLY CHAIN PROCESS
    • ROLE OF MANUFACTURERS
    • ROLE OF DISTRIBUTORS
    • ROLE OF RESEARCH INSTITUTE AND CONSULTANTS
    • ROLE OF GOVERNMENT
    • ROLE OF HOSPITALS AND SURGEONS
  • DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES AND OTHER PARAMETERS INFLUENCING MARKET GROWTH
    • INCIDENCE AND PREVALENCE OF CANCERS
      • TABLE 2: ESTIMATED CANCER DEMOGRAPHICS IN THE U.S., 2016
      • FIGURE 1: DEATHS DUE TO PROSTATE CANCER IN THE U.K., 2014 (%)
    • INCIDENCE AND PREVALENCE RELATING TO CVDS
      • TABLE 3: CARDIOVASCULAR DEMOGRAPHICS IN THE U.S., 2012
      • TABLE 4: EUROPEAN UNION STATISTICS OF CIRCULATORY DISEASES, 2012
      • FIGURE 2: DEATHS DUE TO CARDIOVASCULAR DISEASES IN EUROPE, 2014 (%)
      • FIGURE 3: PREVALENCE OF CIRCULATORY DISEASES IN ADULTS IN THE U.S., AGE GROUP 18 YEARS AND OVER, 2014 (%)
    • INCIDENCE AND PREVALENCE RELATING TO OPHTHALMOLOGY
      • TABLE 5: VISUAL IMPAIRMENT STATISTICS IN THE U.S., 2015 AND 2050
      • FIGURE 4: CAUSES OF VISUAL IMPAIRMENT, 2014 (%)
      • FIGURE 5: NO. OF PEOPLE WITH VISUAL IMPAIRMENT PER MILLION, 2010 (THOUSANDS)
    • FDA GUIDELINES FOR SELECTED PRODUCTS
      • TABLE 6: FDA GUIDELINES FOR SELECTED ABLATION DEVICES
  • REIMBURSEMENT SCENARIO
    • CODING CHANGES FOR CARDIOLOGY
    • ABLATION CODES
      • TABLE 7: FDA GUIDELINES FOR SELECTED ABLATION DEVICES
      • TABLE 8: PHYSICIAN FEE SCHEDULE CODES
    • COMPARISON OF 2012 AND 2013 CODES
      • Case Study I
        • Scenario: Evaluation for a possibility of thrombus before the procedure.
          • TABLE 9: ATRIAL FIBRILLATION ABLATION FOR PULMONARY VEIN ISOLATION
      • Case Study II
        • Scenario: Comprehensive diagnostics of electrophysiology evaluation with stimulation of arrhythmia.
          • TABLE 10: DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY
  • MARKET DYNAMICS
    • TECHNOLOGICAL DEVELOPMENTS
    • HIGHER RISK OF CHRONIC ILLNESSES
      • FIGURE 6: WORLD MORTALITY TRENDS DUE TO CARDIOVASCULAR DISEASES, 2008-2030 (%)
      • FIGURE 7: ESTIMATED NUMBER OF U.S. CANCER SURVIVORS BY SEX AND AGE, 2014 (MILLIONS)
      • TABLE 11: CANCER DEMOGRAPHICS IN EUROPE, 2012
    • ABLATION THERAPY REQUIRES LESS TIME
    • LESS DAMAGE AND BLOOD LOSS
  • RESTRAINTS FOR THE GLOBAL ABLATION DEVICES MARKET
    • PRESSURE FROM REGULATORY AGENCIES
    • INSURANCE SETTLEMENT ISSUES
  • OPPORTUNITIES AND CHALLENGES FOR THE ABLATION DEVICES MARKET
    • GROWING MARKETS IN EMERGING ECONOMIES
    • NEED TO ENHANCE AWARENESS LEVELS

CHAPTER 4 - ABLATION MARKET ANALYSIS BY TECHNOLOGY

  • TABLE 12: GLOBAL MARKET FOR ABLATION DEVICES AND SERVICES, THROUGH 2021 ($ MILLIONS)
  • TABLE 13: GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • THERMAL TECHNOLOGY MARKET
    • TABLE 14: GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • ELECTRICAL ABLATION THERAPY
    • TABLE 15: GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • RADIATION TECHNOLOGY
    • TABLE 16: GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • Types of Radiation Ablation Techniques
      • Intensity-Modulated Radiation Therapy (IMRT)
      • Image-Guided Radiation Therapy (IGRT)
      • Helical Tomography
      • Particle Therapy
      • Stereotactic Radiotherapy
      • Brachytherapy
  • RADIO FREQUENCY (RFID) TECHNOLOGY
    • TABLE 17: GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • Uses of RFA
    • Key Applications of RFA
    • Specific Application of RFID in Therapeutic Segments
      • Treatment of Liver Cancer
      • Treatment of Kidney Cancer
      • Treatment of Lung Cancer
      • Arrhythmias
      • Arthritis Pain
      • Treatment of Varicose Veins
  • LIGHT
    • TABLE 18: GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
  • ULTRASOUND
    • TABLE 19: GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 20: HIFU STUDIES IN KIDNEY TISSUES BY COUNTRY
      • HIFU in Prostate Cancer
      • HIFU in Primary and Secondary Liver Cancer
      • HIFU in Pancreatic Cancer
      • HIFU in Bladder Cancer
    • MICROWAVE
      • TABLE 21: GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • HYDROTHERMAL
      • TABLE 22: GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • NONTHERMAL ABLATION TECHNOLOGY
      • TABLE 23: GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY BY TYPE, THROUGH 2021 ($ MILLIONS)
    • CRYOABLATION
      • TABLE 24: GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • HYDROMECHANICAL
      • TABLE 25: GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)

CHAPTER 5 - ABLATION MARKET ANALYSIS BY PRODUCTS

  • ELECTRICAL
    • TABLE 26: GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 27: GLOBAL MARKET FOR ELECTRICAL ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
  • ELECTRICAL ABLATORS
    • TABLE 28: GLOBAL MARKET FOR ELECTRICAL ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • Argon Plasma/Beam Coagulator
      • TABLE 29: GLOBAL MARKET FOR ARGON PLASMA/BEAM COAGULATOR BY REGION, THROUGH 2021 ($ MILLIONS)
    • Irreversible Electroporation
      • TABLE 30: GLOBAL MARKET FOR IRREVERSIBLE ELECTROPORATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • ELECTRONIC BRACHYTHERAPY
    • TABLE 31: GLOBAL MARKET FOR ELECTRONIC BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • RADIATION
    • TABLE 32: GLOBAL MARKET FOR RADIATION THERAPY BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • BRACHYTHERAPY
    • TABLE 33: GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY PRODUCTS, THROUGH 2021 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY REGION, THROUGH 2021 ($ MILLIONS)
    • High-Dose-Rate (HDR) Brachytherapy
      • TABLE 35: GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • Pulsed-Dose-Rate Brachytherapy
      • TABLE 36: GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • Permanent Seed Brachytherapy or Low-Dose-Rate (LDR) Brachytherapy
      • TABLE 37: GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • STEREOTACTIC RADIOSURGERY AND STEREOTACTIC RADIOTHERAPY
    • TABLE 38: GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) BY REGION, THROUGH 2021 ($ MILLIONS)
  • IMAGE-GUIDED RADIATION THERAPY (IGRT)
    • TABLE 39: GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY REGION, THROUGH 2021 ($ MILLIONS)
  • INTENSITY-MODULATED RADIATION THERAPY (IMRT)
    • TABLE 40: GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY REGION, THROUGH 2021 ($ MILLIONS)
  • STEREOTACTIC BODY RADIATION THERAPY (SBRT)
    • TABLE 41: GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY REGION, THROUGH 2021 ($ MILLIONS)
  • PROTON BEAM THERAPY
    • TABLE 42: GLOBAL MARKET FOR PROTON BEAM THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • RADIO FREQUENCY
    • TABLE 43: GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS)
  • TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES
    • TABLE 44: GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • FLUID-COOLED RF ABLATION
    • TABLE 45: GLOBAL MARKET FOR FLUID-COOLED RF ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • THE ROBOTIC CATHETER MANIPULATION SYSTEM
    • TABLE 46: GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • LIGHT/LASER
    • TABLE 47: GLOBAL MARKET FOR LIGHT/LASER ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
  • COLD LASER
    • TABLE 48: GLOBAL MARKET FOR COLD LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • EXCIMER LASER
    • TABLE 49: GLOBAL MARKET FOR EXCIMER LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • ULTRASOUND
    • TABLE 50: GLOBAL MARKET FOR ULTRASOUND ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
  • HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
    • TABLE 51: GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
  • MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS)
    • TABLE 52: GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
  • ULTRASONIC SURGICAL SYSTEMS
    • TABLE 53: GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY REGION, THROUGH 2021 ($ MILLIONS)
  • EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
    • TABLE 54: GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY REGION, THROUGH 2021 ($ MILLIONS)
  • MICROWAVE ABLATION
  • HYDROTHERMAL ABLATION/ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
  • CRYOABLATION
    • TABLE 55: GLOBAL MARKET FOR CRYOABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
  • TISSUE CONTACT PROBE
    • TABLE 56: GLOBAL MARKET FOR TISSUE CONTACT PROBE BY REGION, THROUGH 2021 ($ MILLIONS)
  • TISSUE SPRAY PROBE
    • TABLE 57: GLOBAL MARKET FOR TISSUE SPRAY PROBE BY REGION, THROUGH 2021 ($ MILLIONS)
  • EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
    • TABLE 58: GLOBAL MARKET FOR EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • ADVANCEMENT IN ROBOTIC ABLATION TECHNIQUE
  • VARIOUS PROCEDURES THAT ARE ROBOTIC IN NATURE
    • STEERABLE CATHETERS
    • HEARTLANDER
    • ROBOTIC RADIOTHERAPY
    • ROBOTIC ABLATION FOR ARRHYTHMIA
    • LEADING ROBOTIC SYSTEMS USED IN CATHETER ABLATION
      • Niobe (Stereotaxis)
      • Sensei (Hansen Medical)
      • Amigo (Catheter Robotics)
      • Artis Zeego (Siemens)
        • TABLE 59: GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
        • TABLE 60: GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
        • TABLE 61: GLOBAL MARKET FOR AUTOMATED/ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
        • TABLE 62: GLOBAL MARKET FOR CONVENTIONAL ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)

CHAPTER 6 - ABLATION MARKET ANALYSIS BY PROCEDURES

  • TABLE 63: GLOBAL MARKET FOR ABLATION DEVICES BY PROCEDURE, THROUGH 2021 ($ MILLIONS)
  • AESTHETICS-SKIN REJUVENATION AND TIGHTENING
    • TABLE 64: GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY REGION, THROUGH 2021 ($ MILLIONS)
    • LASER SKIN REJUVENATION
    • ILLUSTRATION: SOURCE-VICTORIAN COSMETIC INSTITUTE'S CASE STUDIES
  • RADIO FREQUENCY (RF) FOR FACIAL SKIN REJUVENATION
  • AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE
    • TABLE 65: GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE BY REGION, THROUGH 2021 ($ MILLIONS)
    • HIFU FOR FAT REDUCTION
    • ILLUSTRATION: SOURCE-ELSEVIER HEALTH JOURNAL
    • VACUUM MASSAGE FOR CELLULITE REDUCTION
  • BENIGN PROSTATIC HYPERPLASIA
    • TABLE 66: GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA BY REGION, THROUGH 2021 ($ MILLIONS)
    • GREENLIGHT LASER PROCEDURE FOR BENIGN PROSTATE
    • ILLUSTRATIONS: SOURCE-EUROPEAN UROLOGY CENTER
    • THERMOTHERAPY FOR BENIGN PROSTATE
  • TRANSURETHRAL NEEDLE ABLATION
    • TABLE 67: GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • ILLUSTRATIONS: SOURCE-DIVISION OF UROLOGY, JOHANNESBURG HOSPITAL, SOUTH AFRICA
    • LASER AND OTHER ENERGY-BASED THERAPIES/HOLMIUM LASER ABLATION/ENUCLEATION OF THE PROSTATE
  • HOLMIUM LASER ENUCLEATION OF PROSTATE CANCER
    • TABLE 68: GLOBAL MARKET FOR LASER AND OTHER ENERGY-BASED ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • ILLUSTRATION
  • ATRIAL FIBRILLATION ABLATION
    • TABLE 69: GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • PAROXYSMAL ATRIAL FIBRILLATION
    • PERSISTENT ATRIAL FIBRILLATION
  • CANCER/TUMOR ABLATION
    • TABLE 70: GLOBAL MARKET FOR TUMOR/CANCER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
  • MENORRHAGIA/ENDOMETRIAL ABLATION
    • TABLE 71: GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • HEATED BALLOON PROCEDURE
  • SPINAL DECOMPRESSION AND DENERVATION
    • TABLE 72: GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • DIAGNOSTIC MEDIAL BRANCH BLOCK (MBB)
    • RADIO FREQUENCY ABLATION (RFA) FOR BACK PAIN
  • STRESS URINARY INCONTINENCE
    • TABLE 73: GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TRANSURETHRAL RADIO FREQUENCY COLLAGEN DENATURATION
  • VARICOSE VEIN ABLATION
    • TABLE 74: GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • RADIO FREQUENCY ABLATION (RFA) FOR VARICOSE VEINS
  • UTERINE FIBROIDS
    • TABLE 75: GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOR TERINE FIBROIDS
  • OTHER PROCEDURES
    • TABLE 76: GLOBAL MARKET FOR OTHER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
  • ELASA EYE SURGERY

CHAPTER 7 - ABLATION MARKET ANALYSIS BY THERAPEUTICS

  • TABLE 77: GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2021 ($ MILLIONS)
  • CANCER/ONCOLOGY
    • TABLE 78: GLOBAL MARKET FOR CANCER ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • CARDIOVASCULAR
    • TABLE 79: GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • OPHTHALMOLOGY
    • TABLE 80: GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • COSMETOLOGY
  • GYNECOLOGY
    • TABLE 81: GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • UROLOGY
    • TABLE 82: GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
  • CRYOABLATION FOR PROSTATE CANCER
  • ORTHOPEDICS
    • TABLE 83: GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • RADIO FREQUENCY ABLATION (RFA) FOR ORTHOPEDIC TREATMENT
  • PAIN MANAGEMENT
    • CRYOABLATION IN PAIN MANAGEMENT
  • OTHERS
    • TABLE 84: GLOBAL MARKET FOR OTHER THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • COBLATION FOR TONSILS
    • PORT-WINE STAINS
    • ABLATION OF PORT-WINE STAINS

CHAPTER 8 - COMPETITIVE LANDSCAPE

  • FIGURE 8: KEY COMPETITIVE STRATEGIES, 2014-2016 (%)
  • CLEARANCES AND APPROVALS
    • FIGURE 9: CLEARANCE AND APPROVAL STRATEGY BY COMPANY, 2014-2016 (%)
    • TABLE 85: KEY CLEARANCES AND APPROVALS ANNOUNCED BETWEEN 2014 AND 2016
  • ACQUISITIONS
    • FIGURE 10: ACQUISITION STRATEGY BY COMPANIES, 2014-2016 (%)
    • TABLE 86: KEY ACQUISITIONS ANNOUNCED BETWEEN 2014 AND 2016
  • AGREEMENTS
    • FIGURE 11: AGREEMENT STRATEGY BY COMPANY, 2014-2016 (%)
    • TABLE 87: KEY AGREEMENTS ANNOUNCED BETWEEN 2014 AND 2016
  • PRODUCT LAUNCH
    • FIGURE 12: PRODUCT LAUNCH STRATEGY BY COMPANIES, 2014-2016 (%)
    • TABLE 88: KEY PRODUCT LAUNCH ANNOUNCED BETWEEN 2014 AND 2016

CHAPTER 9 - GEOGRAPHIC ANALYSIS

  • NORTH AMERICA
    • TABLE 89: NORTH AMERICA ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • EUROPE
    • TABLE 90: EUROPEAN ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 91: ASIA-PACIFIC ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
  • ROW
    • TABLE 92: ROW ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)

CHAPTER 10 - PATENT ANALYSIS

  • FIGURE 13: SHARES OF PATENTS REGISTERED/APPROVED BY COUNTRY, 2013 THROUGH NOV. 2016 (%)
  • PATENT ANALYSIS BY MARKET PARTICIPANTS
    • FIGURE 14: PATENT SHARES BY MARKET PARTICIPANT, 2013 THROUGH NOV. 2016 (%)
  • PATENT ANALYSIS BY YEAR
    • FIGURE 15: PATENT ANALYSIS BY YEAR, 2013 THROUGH NOV. 2016 (%)

CHAPTER 11 - COMPANY PROFILES

  • ABBOTT LABORATORIES
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 93: ABBOTT LABORATORIES RECENT DEVELOPMENTS, 2014-2016
      • TABLE 94: ABBOTT LABORATORIES FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • ACCURAY INC.
    • ACCURAY PRODUCT PORTFOLIO
      • TABLE 95: ACCURAY RECENT DEVELOPMENTS, 2014-2016
      • TABLE 96: ACCURAY FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • ALCON LABORATORIES INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 97: ALCON RECENT DEVELOPMENTS, 2014-2016
      • TABLE 98: ALCON FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • ANGIODYNAMICS INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 99: ANGIODYNAMICS RECENT DEVELOPMENTS, 2014-2016
      • TABLE 100: ANGIODYNAMICS FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • ATRICURE INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 101: ATRICURE RECENT DEVELOPMENTS, 2014-2016
      • TABLE 102: ATRICURE FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • BIOSENSE WEBSTER
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 103: BIOSENSE WEBSTER RECENT DEVELOPMENTS, 2014-2016
      • TABLE 104: BIOSENSE WEBSTER FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • BOSTON SCIENTIFIC CORP.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 105: BOSTON SCIENTIFIC CORP. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 106: BOSTON SCIENTIFIC CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • BTG PLC
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 107: BTG PLC RECENT DEVELOPMENTS, 2014-2016
      • TABLE 108: BTG PLC FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • CONMED CORP.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 109: CONMED RECENT DEVELOPMENTS, 2014-2016
      • TABLE 110: CONMED FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • C.R. BARD INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 111: C.R. BARD RECENT DEVELOPMENTS, 2014-2016
      • TABLE 112: C.R. BARD FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • EDAP TMS S.A.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 113: EDAP TMS S.A. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 114: EDAP TMS S.A. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • ELEKTA AB
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 115: ELEKTA AB RECENT DEVELOPMENTS, 2014-2016
      • TABLE 116: ELEKTA AB FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • HAYLARD HEALTH INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 117: HAYLARD HEALTH INC. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 118: HAYLARD HEALTH INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • HOLOGIC INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 119: HOLOGIC INC. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 120: HOLOGIC INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • INTEGRA LIFESCIENCES HOLDINGS CORP.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 121: INTEGRA LIFESCIENCES HOLDINGS CORP. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 122: INTEGRA LIFESCIENCES HOLDINGS CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • JAPAN LIFELINE CO. LTD.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 123: JAPAN LIFELINE CO. LTD. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 124: JAPAN LIFELINE CO. LTD. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • MEDTRONIC PLC
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 125: MEDTRONIC PLC RECENT DEVELOPMENTS, 2014-2016
      • TABLE 126: MEDTRONIC PLC FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • MERIT MEDICAL SYSTEMS INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 127: MERIT MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 128: MERIT MEDICAL SYSTEMS INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • MISONIX INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 129: MISONIX INC. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 130: MISONIX FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • OLYMPUS CORP.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 131: OLYMPUS RECENT DEVELOPMENTS, 2014-2016
      • TABLE 132: OLYMPUS FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • SMITH & NEPHEW PLC
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 133: SMITH & NEPHEW RECENT DEVELOPMENTS, 2014-2016
      • TABLE 134: SMITH & NEPHEW FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • ST. JUDE MEDICAL INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 135: ST. JUDE MEDICAL RECENT DEVELOPMENTS, 2014-2016
      • TABLE 136: ST. JUDE MEDICAL FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • STRYKER CORP.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 137: STRYKER CORP. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 138: STRYKER CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • TERUMO MEDICAL CORP.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 139: TERUMO MEDICAL CORP. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 140: TERUMO MEDICAL CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
  • VARIAN MEDICAL SYSTEMS INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 141: VARIAN MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016
      • TABLE 142: VARIAN MEDICAL SYSTEMS INC., 2013-2015 ($ MILLIONS/%)

CHAPTER 12 - APPENDIX

  • TABLE 143: U.S. PATENTS, 2013 THROUGH OCT. 2016
  • TABLE 144: EUROPEAN PATENTS, 2013 THROUGH NOV. 2016
  • TABLE 145: JAPANESE PATENTS, 2013-2015
  • TABLE 146: CHINESE PATENTS, 2013-2015
  • TABLE 147: CANADIAN PATENTS, 2013-2015
  • TABLE 148: ROW PATENTS, 2013-2015

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: DEVICES YET TO BE APPROVED FOR ATRIAL FIBRILLATION TREATMENT
    • TABLE 2: ESTIMATED CANCER DEMOGRAPHICS IN THE U.S., 2016
    • TABLE 3: CARDIOVASCULAR DEMOGRAPHICS IN THE U.S., 2012
    • TABLE 4: EUROPEAN UNION STATISTICS OF CIRCULATORY DISEASES, 2012
    • TABLE 5: VISUAL IMPAIRMENT STATISTICS IN THE U.S., 2015 AND 2050
    • TABLE 6: FDA GUIDELINES FOR SELECTED ABLATION DEVICES
    • TABLE 7: FDA GUIDELINES FOR SELECTED ABLATION DEVICES
    • TABLE 8: PHYSICIAN FEE SCHEDULE CODES
    • TABLE 9: ATRIAL FIBRILLATION ABLATION FOR PULMONARY VEIN ISOLATION
    • TABLE 10: DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY
    • TABLE 11: CANCER DEMOGRAPHICS IN EUROPE, 2012
    • TABLE 12: GLOBAL MARKET FOR ABLATION DEVICES AND SERVICES, THROUGH 2021 ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 18: GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 19: GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 20: HIFU STUDIES IN KIDNEY TISSUES BY COUNTRY
    • TABLE 21: GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 25: GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 26: GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 27: GLOBAL MARKET FOR ELECTRICAL ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 28: GLOBAL MARKET FOR ELECTRICAL ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 29: GLOBAL MARKET FOR ARGON PLASMA/BEAM COAGULATOR BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 30: GLOBAL MARKET FOR IRREVERSIBLE ELECTROPORATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 31: GLOBAL MARKET FOR ELECTRONIC BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR RADIATION THERAPY BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 33: GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY PRODUCTS, THROUGH 2021 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 35: GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 40: GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 42: GLOBAL MARKET FOR PROTON BEAM THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 44: GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 45: GLOBAL MARKET FOR FLUID-COOLED RF ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 46: GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 47: GLOBAL MARKET FOR LIGHT/LASER ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 48: GLOBAL MARKET FOR COLD LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 49: GLOBAL MARKET FOR EXCIMER LASER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 50: GLOBAL MARKET FOR ULTRASOUND ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 51: GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 52: GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGFUS) ABLATORS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 53: GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 54: GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 55: GLOBAL MARKET FOR CRYOABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 56: GLOBAL MARKET FOR TISSUE CONTACT PROBE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 57: GLOBAL MARKET FOR TISSUE SPRAY PROBE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 58: GLOBAL MARKET FOR EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 59: GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 60: GLOBAL MARKET FOR ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 61: GLOBAL MARKET FOR AUTOMATED/ROBOTIC ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 62: GLOBAL MARKET FOR CONVENTIONAL ABLATION DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 63: GLOBAL MARKET FOR ABLATION DEVICES BY PROCEDURE, THROUGH 2021 ($ MILLIONS)
    • TABLE 64: GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 65: GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 66: GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 67: GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 68: GLOBAL MARKET FOR LASER AND OTHER ENERGY-BASED ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 69: GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 70: GLOBAL MARKET FOR TUMOR/CANCER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 71: GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 72: GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 73: GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 74: GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 75: GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 76: GLOBAL MARKET FOR OTHER ABLATION PROCEDURE BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 77: GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2021 ($ MILLIONS)
    • TABLE 78: GLOBAL MARKET FOR CANCER ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 79: GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 80: GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 81: GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 82: GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 83: GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 84: GLOBAL MARKET FOR OTHER THERAPY BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 85: KEY CLEARANCES AND APPROVALS ANNOUNCED BETWEEN 2014 AND 2016
    • TABLE 86: KEY ACQUISITIONS ANNOUNCED BETWEEN 2014 AND 2016
    • TABLE 87: KEY AGREEMENTS ANNOUNCED BETWEEN 2014 AND 2016
    • TABLE 88: KEY PRODUCT LAUNCH ANNOUNCED BETWEEN 2014 AND 2016
    • TABLE 89: NORTH AMERICA ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 90: EUROPEAN ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 91: ASIA-PACIFIC ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 92: ROW ABLATION MARKET BY TECHNOLOGY, THROUGH 2021 ($ MILLIONS)
    • TABLE 93: ABBOTT LABORATORIES RECENT DEVELOPMENTS, 2014-2016
    • TABLE 94: ABBOTT LABORATORIES FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 95: ACCURAY RECENT DEVELOPMENTS, 2014-2016
    • TABLE 96: ACCURAY FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 97: ALCON RECENT DEVELOPMENTS, 2014-2016
    • TABLE 98: ALCON FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 99: ANGIODYNAMICS RECENT DEVELOPMENTS, 2014-2016
    • TABLE 100: ANGIODYNAMICS FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 101: ATRICURE RECENT DEVELOPMENTS, 2014-2016
    • TABLE 102: ATRICURE FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 103: BIOSENSE WEBSTER RECENT DEVELOPMENTS, 2014-2016
    • TABLE 104: BIOSENSE WEBSTER FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 105: BOSTON SCIENTIFIC CORP. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 106: BOSTON SCIENTIFIC CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 107: BTG PLC RECENT DEVELOPMENTS, 2014-2016
    • TABLE 108: BTG PLC FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 109: CONMED RECENT DEVELOPMENTS, 2014-2016
    • TABLE 110: CONMED FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 111: C.R. BARD RECENT DEVELOPMENTS, 2014-2016
    • TABLE 112: C.R. BARD FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 113: EDAP TMS S.A. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 114: EDAP TMS S.A. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 115: ELEKTA AB RECENT DEVELOPMENTS, 2014-2016
    • TABLE 116: ELEKTA AB FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 117: HAYLARD HEALTH INC. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 118: HAYLARD HEALTH INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 119: HOLOGIC INC. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 120: HOLOGIC INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 121: INTEGRA LIFESCIENCES HOLDINGS CORP. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 122: INTEGRA LIFESCIENCES HOLDINGS CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 123: JAPAN LIFELINE CO. LTD. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 124: JAPAN LIFELINE CO. LTD. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 125: MEDTRONIC PLC RECENT DEVELOPMENTS, 2014-2016
    • TABLE 126: MEDTRONIC PLC FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 127: MERIT MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 128: MERIT MEDICAL SYSTEMS INC. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 129: MISONIX INC. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 130: MISONIX FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 131: OLYMPUS RECENT DEVELOPMENTS, 2014-2016
    • TABLE 132: OLYMPUS FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 133: SMITH & NEPHEW RECENT DEVELOPMENTS, 2014-2016
    • TABLE 134: SMITH & NEPHEW FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 135: ST. JUDE MEDICAL RECENT DEVELOPMENTS, 2014-2016
    • TABLE 136: ST. JUDE MEDICAL FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 137: STRYKER CORP. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 138: STRYKER CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 139: TERUMO MEDICAL CORP. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 140: TERUMO MEDICAL CORP. FINANCIALS, 2013-2015 ($ MILLIONS/%)
    • TABLE 141: VARIAN MEDICAL SYSTEMS INC. RECENT DEVELOPMENTS, 2014-2016
    • TABLE 142: VARIAN MEDICAL SYSTEMS INC., 2013-2015 ($ MILLIONS/%)
    • TABLE 143: U.S. PATENTS, 2013 THROUGH OCT. 2016
    • TABLE 144: EUROPEAN PATENTS, 2013 THROUGH NOV. 2016
    • TABLE 145: JAPANESE PATENTS, 2013-2015
    • TABLE 146: CHINESE PATENTS, 2013-2015
    • TABLE 147: CANADIAN PATENTS, 2013-2015
    • TABLE 148: ROW PATENTS, 2013-2015

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR ABLATION DEVICES BY REGION, 2015-2021 ($ MILLIONS)
    • FIGURE 1: DEATHS DUE TO PROSTATE CANCER IN THE U.K., 2014 (%)
    • FIGURE 2: DEATHS DUE TO CARDIOVASCULAR DISEASES IN EUROPE, 2014 (%)
    • FIGURE 3: PREVALENCE OF CIRCULATORY DISEASES IN ADULTS IN THE U.S., AGE GROUP 18 YEARS AND OVER, 2014 (%)
    • FIGURE 4: CAUSES OF VISUAL IMPAIRMENT, 2014 (%)
    • FIGURE 5: NO. OF PEOPLE WITH VISUAL IMPAIRMENT PER MILLION, 2010 (THOUSANDS)
    • FIGURE 6: WORLD MORTALITY TRENDS DUE TO CARDIOVASCULAR DISEASES, 2008-2030 (%)
    • FIGURE 7: ESTIMATED NUMBER OF U.S. CANCER SURVIVORS BY SEX AND AGE, 2014 (MILLIONS)
    • FIGURE 8: KEY COMPETITIVE STRATEGIES, 2014-2016 (%)
    • FIGURE 9: CLEARANCE AND APPROVAL STRATEGY BY COMPANY, 2014-2016 (%)
    • FIGURE 10: ACQUISITION STRATEGY BY COMPANIES, 2014-2016 (%)
    • FIGURE 11: AGREEMENT STRATEGY BY COMPANY, 2014-2016 (%)
    • FIGURE 12: PRODUCT LAUNCH STRATEGY BY COMPANIES, 2014-2016 (%)
    • FIGURE 13: SHARES OF PATENTS REGISTERED/APPROVED BY COUNTRY, 2013 THROUGH NOV. 2016 (%)
    • FIGURE 14: PATENT SHARES BY MARKET PARTICIPANT, 2013 THROUGH NOV. 2016 (%)
    • FIGURE 15: PATENT ANALYSIS BY YEAR, 2013 THROUGH NOV. 2016 (%)
Back to Top